Aia Group LTD Denali Therapeutics Inc. Transaction History

Aia Group LTD

$3.67 Billion
Q3 2024

A detailed history of Aia Group LTD transactions in Denali Therapeutics Inc. stock. As of the latest transaction made, Aia Group LTD holds 74,815 shares of DNLI stock, worth $1.81 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

74,815

Previous 69,344 7.89%

Holding current value

$1.81 Million

Previous $1.61 Million 35.34%

% of portfolio

0.06%

Previous 0.05%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 31, 2024	BUY	$20.96 - $31.05 $114,672 - $169,874	5,471 Added 7.89%	74,815 $2.18 Million
Q2 2024 Jul 31, 2024	BUY	$14.96 - $23.22 $124,317 - $192,958	8,310 Added 13.62%	69,344 $1.61 Million
Q1 2024 May 06, 2024	SELL	$15.83 - $23.35 $111,506 - $164,477	-7,044 Reduced 10.35%	61,034 $1.25 Million
Q4 2023 Jan 31, 2024	SELL	$16.2 - $23.18 $5,977 - $8,553	-369 Reduced 0.54%	68,078 $1.46 Million
Q3 2023 Nov 01, 2023	BUY	$20.63 - $30.17 $251,747 - $368,164	12,203 Added 21.7%	68,447 $1.41 Million
Q2 2023 Jul 28, 2023	BUY	$23.37 - $32.96 $139,752 - $197,100	5,980 Added 11.9%	56,244 $1.66 Million
Q1 2023 Apr 28, 2023	BUY	$21.91 - $32.67 $602,568 - $898,490	27,502 Added 120.82%	50,264 $1.16 Million
Q4 2022 Jan 31, 2023	SELL	$26.28 - $33.92 $374,857 - $483,834	-14,264 Reduced 38.52%	22,762 $633,000
Q3 2022 Nov 04, 2022	SELL	$25.97 - $38.53 $986 - $1,464	-38 Reduced 0.1%	37,026 $1.14 Million
Q2 2022 Aug 11, 2022	SELL	$20.88 - $35.19 $90,222 - $152,055	-4,321 Reduced 10.44%	37,064 $1.09 Million
Q1 2022 May 06, 2022	SELL	$29.0 - $47.27 $1.93 Million - $3.14 Million	-66,457 Reduced 61.62%	41,385 $1.33 Million
Q4 2021 Feb 11, 2022	BUY	$42.59 - $55.02 $400,388 - $517,243	9,401 Added 9.55%	107,842 $4.81 Million
Q3 2021 Nov 05, 2021	BUY	$48.48 - $78.23 $802,344 - $1.29 Million	16,550 Added 20.21%	98,441 $4.97 Million
Q2 2021 Aug 03, 2021	BUY	$50.3 - $78.44 $1.38 Million - $2.16 Million	27,516 Added 50.6%	81,891 $5.3 Million
Q1 2021 May 14, 2021	BUY	$53.8 - $81.53 $965,010 - $1.46 Million	17,937 Added 49.23%	54,375 $3.11 Million
Q4 2020 Feb 12, 2021	BUY	$36.89 - $93.56 $1.34 Million - $3.41 Million	36,438 New	36,438 $2.49 Million

Others Institutions Holding DNLI

# of Institutions

228

Shares Held

120M

Call Options Held

60.6K

Put Options Held

48.4K

View Full List

About Denali Therapeutics Inc.

Ticker DNLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 134,174,000
Market Cap $3.24B
Description
Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...

More about DNLI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aia Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Aia Group LTD with notifications on news.

Account